These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 34218710)

  • 21. Nuisance compounds in cellular assays.
    Dahlin JL; Auld DS; Rothenaigner I; Haney S; Sexton JZ; Nissink JWM; Walsh J; Lee JA; Strelow JM; Willard FS; Ferrins L; Baell JB; Walters MA; Hua BK; Hadian K; Wagner BK
    Cell Chem Biol; 2021 Mar; 28(3):356-370. PubMed ID: 33592188
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Advancing Biological Understanding and Therapeutics Discovery with Small-Molecule Probes.
    Schreiber SL; Kotz JD; Li M; Aubé J; Austin CP; Reed JC; Rosen H; White EL; Sklar LA; Lindsley CW; Alexander BR; Bittker JA; Clemons PA; de Souza A; Foley MA; Palmer M; Shamji AF; Wawer MJ; McManus O; Wu M; Zou B; Yu H; Golden JE; Schoenen FJ; Simeonov A; Jadhav A; Jackson MR; Pinkerton AB; Chung TD; Griffin PR; Cravatt BF; Hodder PS; Roush WR; Roberts E; Chung DH; Jonsson CB; Noah JW; Severson WE; Ananthan S; Edwards B; Oprea TI; Conn PJ; Hopkins CR; Wood MR; Stauffer SR; Emmitte KA;
    Cell; 2015 Jun; 161(6):1252-65. PubMed ID: 26046436
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-throughput screening with nucleosome substrate identifies small-molecule inhibitors of the human histone lysine methyltransferase NSD2.
    Coussens NP; Kales SC; Henderson MJ; Lee OW; Horiuchi KY; Wang Y; Chen Q; Kuznetsova E; Wu J; Chakka S; Cheff DM; Cheng KC; Shinn P; Brimacombe KR; Shen M; Simeonov A; Lal-Nag M; Ma H; Jadhav A; Hall MD
    J Biol Chem; 2018 Aug; 293(35):13750-13765. PubMed ID: 29945974
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The European Lead Factory: An updated HTS compound library for innovative drug discovery.
    van Vlijmen H; Ortholand JY; Li VM; de Vlieger JSB
    Drug Discov Today; 2021 Oct; 26(10):2406-2413. PubMed ID: 33892142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Post-HTS case report and structural alert: Promiscuous 4-aroyl-1,5-disubstituted-3-hydroxy-2H-pyrrol-2-one actives verified by ALARM NMR.
    Dahlin JL; Nissink JWM; Francis S; Strasser JM; John K; Zhang Z; Walters MA
    Bioorg Med Chem Lett; 2015 Nov; 25(21):4740-4752. PubMed ID: 26318992
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validating ADME QSAR Models Using Marketed Drugs.
    Siramshetty V; Williams J; Nguyễn ÐT; Neyra J; Southall N; Mathé E; Xu X; Shah P
    SLAS Discov; 2021 Dec; 26(10):1326-1336. PubMed ID: 34176369
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hit Discovery for Public Target Programs in the European Lead Factory: Experiences and Output from Assay Development and Ultra-High-Throughput Screening.
    Honarnejad S; van Boeckel S; van den Hurk H; van Helden S
    SLAS Discov; 2021 Feb; 26(2):192-204. PubMed ID: 32734803
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The European Lead Factory: Results from a decade of collaborative, public-private, drug discovery programs.
    van Vlijmen H; Pannifer AD; Cochrane P; Basting D; Li VM; Engkvist O; Ortholand JY; Wagener M; Duffy J; Finsinger D; Davis J; van Helden SP; de Vlieger JSB;
    Drug Discov Today; 2024 Mar; 29(3):103886. PubMed ID: 38244673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. PubChem 2019 update: improved access to chemical data.
    Kim S; Chen J; Cheng T; Gindulyte A; He J; He S; Li Q; Shoemaker BA; Thiessen PA; Yu B; Zaslavsky L; Zhang J; Bolton EE
    Nucleic Acids Res; 2019 Jan; 47(D1):D1102-D1109. PubMed ID: 30371825
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Optimal HTS Fingerprint Definitions by Using a Desirability Function and a Genetic Algorithm.
    Cortes Cabrera A; Petrone PM
    J Chem Inf Model; 2018 Mar; 58(3):641-646. PubMed ID: 29425455
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Impact of Assay Design on Medicinal Chemistry: Case Studies.
    Born JR; Chenniappan VK; Davis DP; Dahlin JL; Marugan JJ; Patnaik S
    SLAS Discov; 2021 Dec; 26(10):1243-1255. PubMed ID: 34225522
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cheminformatics approaches to analyze diversity in compound screening libraries.
    Akella LB; DeCaprio D
    Curr Opin Chem Biol; 2010 Jun; 14(3):325-30. PubMed ID: 20457001
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Lies and Liabilities: Computational Assessment of High-Throughput Screening Hits to Identify Artifact Compounds.
    Alves VM; Yasgar A; Wellnitz J; Rai G; Rath M; Braga RC; Capuzzi SJ; Simeonov A; Muratov EN; Zakharov AV; Tropsha A
    J Med Chem; 2023 Sep; 66(18):12828-12839. PubMed ID: 37677128
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A Guide to Run Affinity Screens Using Differential Scanning Fluorimetry and Surface Plasmon Resonance Assays.
    Bergsdorf C; Wright SK
    Methods Enzymol; 2018; 610():135-165. PubMed ID: 30390797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Cell Painting-based bioactivity prediction boosts high-throughput screening hit-rates and compound diversity.
    Fredin Haslum J; Lardeau CH; Karlsson J; Turkki R; Leuchowius KJ; Smith K; Müllers E
    Nat Commun; 2024 Apr; 15(1):3470. PubMed ID: 38658534
    [TBL] [Abstract][Full Text] [Related]  

  • 36. High-Throughput Screening of Transient Receptor Potential Channel 1 Ligands in the Light of the Bioluminescence Resonance Energy Transfer Technique.
    Chappe Y; Michel P; Joushomme A; Barbeau S; Pierredon S; Baron L; Garenne A; Poulletier De Gannes F; Hurtier A; Mayer S; Lagroye I; Quignard JF; Ducret T; Compan V; Franchet C; Percherancier Y
    Mol Pharmacol; 2021 Sep; 100(3):237-257. PubMed ID: 34127538
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Overview of high-throughput screening.
    Entzeroth M; Flotow H; Condron P
    Curr Protoc Pharmacol; 2009 Mar; Chapter 9():Unit 9.4. PubMed ID: 22294406
    [TBL] [Abstract][Full Text] [Related]  

  • 38. National Institutes of Health. Drug-screening program looking for a home.
    Kaiser J
    Science; 2011 Oct; 334(6054):299. PubMed ID: 22021828
    [No Abstract]   [Full Text] [Related]  

  • 39. Physiologically relevant orthogonal assays for the discovery of small-molecule modulators of WIP1 phosphatase in high-throughput screens.
    Clausse V; Tao D; Debnath S; Fang Y; Tagad HD; Wang Y; Sun H; LeClair CA; Mazur SJ; Lane K; Shi ZD; Vasalatiy O; Eells R; Baker LK; Henderson MJ; Webb MR; Shen M; Hall MD; Appella E; Appella DH; Coussens NP
    J Biol Chem; 2019 Nov; 294(46):17654-17668. PubMed ID: 31481464
    [TBL] [Abstract][Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.